Detalles de la búsqueda
1.
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Int J Mol Sci
; 24(22)2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38003302
2.
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology.
Oncologist
; 27(9): 778-789, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35781739
3.
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Mol Cancer
; 20(1): 85, 2021 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092233
4.
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II Study.
Oncologist
; 26(9): 731-e1498, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33861486
5.
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
Breast Cancer Res Treat
; 184(2): 357-364, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32767201
6.
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38714474
7.
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma.
Cancers (Basel)
; 15(14)2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509357
8.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
J Clin Oncol
; 41(21): 3712-3723, 2023 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192435
9.
An APPL1/Akt signaling complex regulates dendritic spine and synapse formation in hippocampal neurons.
Mol Cell Neurosci
; 46(3): 633-44, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21236345
10.
Immune-checkpoint inhibitors: long-term implications of toxicity.
Nat Rev Clin Oncol
; 19(4): 254-267, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35082367
11.
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients.
NPJ Precis Oncol
; 6(1): 6, 2022 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058553
12.
Evaluation of healthcare-associated infection rates in patients with hematologic malignancies and stem cell transplantation during the coronavirus disease 2019 (COVID-19) pandemic.
Antimicrob Steward Healthc Epidemiol
; 2(1): e11, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36310802
13.
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors.
JCO Precis Oncol
; 6: e2200107, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977349
14.
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
J Clin Oncol
; 40(10): 1068-1080, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35143285
15.
Vasodilator-stimulated phosphoprotein (VASP) induces actin assembly in dendritic spines to promote their development and potentiate synaptic strength.
J Biol Chem
; 285(46): 36010-20, 2010 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-20826790
16.
Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety.
Expert Rev Anticancer Ther
; 21(6): 583-590, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33504219
17.
Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy.
Front Immunol
; 12: 786046, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34868071
18.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
JAMA Oncol
; 7(12): 1856-1861, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734989
19.
Predictive biomarkers of response to immune checkpoint inhibitors in melanoma.
Expert Rev Anticancer Ther
; 20(2): 137-145, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997676
20.
MEK inhibitors in non-V600 BRAF mutations and fusions.
Oncotarget
; 11(44): 3900-3903, 2020 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33216832